Das, Alakesh, Suman Adhikari, Dikshita Deka, Atil Bisgin, Sujay Paul, Nabajyoti Balidya, Ibrahim Boga, Antara Banerjee, and Surajit Pathak.
Abstract:
Breast cancer is among the most frequently occurring cancer for women globally. Conventional therapies for breast cancer are found to be expensive and cause severe aftereffects; further increasing drug resistance is also attracting the interest of researchers to explore novel therapeutic strategies to treat breast cancer. Among the cutting-edge approaches, several therapeutic peptides that target and destroy tumour cells have attracted much concern. Short chains of amino acids known as therapeutic peptides have a high affinity for binding and regulating a specific protein interaction. A reliable way to get around the issues with other therapies is through targeted therapy. Additionally, it enables medications to selectively localize at predetermined locations. Therapeutic peptides are an innovative and promising method for treating solid tumours, notably breast cancer. The aim of this review article is to give an extensive and informative overview of therapeutic peptides and how they are used to treat breast cancer. Research into new, efficient therapeutic approaches for breast cancer treatment can be supported by the development of beneficial therapeutic technologies, like therapeutic peptides and their different anti-cancerous potential against tumor cells.